Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2024, 6(2); doi: 10.25236/FMSR.2024.060208.

Association between Triglyceride-glucose Index and Osteoporosis: A Cross-sectional Study Based on the National Health and Nutrition Examination Survey


Xiao Zhou1, Yan Zhu2

Corresponding Author:
Xiao Zhou

1Department of Endocrinology, Zhuji People's Hospital, Shaoxing, 311800, China

2Department of Spine Surgery, Zhuji People's Hospital, Shaoxing, 311800, China


Triglyceride-glucose (TyG) index is a substitute index for insulin resistance, and has been reported to be associated with many diseases, such as myocardial infarction, stroke, hypertension, and depression, while its association with osteoporosis has not been reported. Therefore, this study aims to explore the association between TyG index and osteoporosis. This was a cross-sectional study, and data were extracted from the National Health and Nutrition Examination Survey (NHANES). The association between TyG index and osteoporosis was assessed using logistic regression analysis, and results were shown as odds ratio (OR) and 95% confidence intervals (95%CI). Subgroup analysis was also performed based on age, BMI, and diabetes. A total of 4,351 participants were finally included, with 2,149 female and 2,202 male. After adjusting potential confounders, we found that higher level of TyG index was significantly associated with higher odds of osteoporosis in female with BMI > 30 kg/m2 (OR = 1.88, 95%CI: 1.10-3.19). Moreover, TyG index was associated with osteoporosis in male with age < 65 years (OR = 2.16, 95%CI: 1.13-4.13), with BMI < 25 kg/m2 (OR = 1.86, 95%CI: 1.01-3.42), or without diabetes (OR = 2.24, 95%CI: 1.26-3.97). High TyG index was associated with the high odds of osteoporosis in male with age < 65 years, with BMI < 25 kg/m2, or without diabetes, and in female with BMI > 30 kg/m2. Future studies are needed to verify our findings.


triglyceride-glucose index, osteoporosis, body mass index, gender

Cite This Paper

Xiao Zhou, Yan Zhu. Association between Triglyceride-glucose Index and Osteoporosis: A Cross-sectional Study Based on the National Health and Nutrition Examination Survey. Frontiers in Medical Science Research (2024), Vol. 6, Issue 2: 43-48. https://doi.org/10.25236/FMSR.2024.060208.


[1] Khandelwal, S. and N.E. Lane, Osteoporosis: Review of Etiology, Mechanisms, and Approach to Management in the Aging Population. Endocrinol Metab Clin North Am, 2023. 52(2): p. 259-275.

[2] Zou, Z., et al., Advances in the occurrence and biotherapy of osteoporosis. Biochem Soc Trans, 2020. 48(4): p. 1623-1636.

[3] Fu, Y.H., et al., Associations of insulin resistance and insulin secretion with bone mineral density and osteoporosis in a general population. Front Endocrinol (Lausanne), 2022. 13: p. 971960.

[4] Shieh, A., et al., Longitudinal associations of insulin resistance with change in bone mineral density in midlife women. JCI Insight, 2022. 7(20).

[5] DeFronzo, R.A., J.D. Tobin, and R. Andres, Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol, 1979. 237(3): p. E214-223.

[6] Zhou, Y., et al., The U-Shape Relationship between Triglyceride-Glucose Index and the Risk of Diabetic Retinopathy among the US Population. J Pers Med, 2023. 13(3).

[7] Matthews, D.R., et al., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985. 28(7): p. 412-419.

[8] Simental-Mendía, L.E., M. Rodríguez-Morán, and F. Guerrero-Romero, The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord, 2008. 6(4): p. 299-304.

[9] Guerrero-Romero, F., et al., The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab, 2010. 95(7): p. 3347-3351.

[10] Wang, S., et al., Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 diabetes: a real-world single-centre study. Cardiovasc Diabetol, 2021. 20(1): p. 82.

[11] Tian, X., et al., Triglyceride-glucose index is associated with the risk of myocardial infarction: an 11-year prospective study in the Kailuan cohort. Cardiovasc Diabetol, 2021. 20(1): p. 19.

[12] Wang, A., et al., Triglyceride-glucose index and the risk of stroke and its subtypes in the general population: an 11-year follow-up. Cardiovasc Diabetol, 2021. 20(1): p. 46.

[13] Wang, Y., W. Yang, and X. Jiang, Association Between Triglyceride-Glucose Index and Hypertension: A Meta-Analysis. Front Cardiovasc Med, 2021. 8: p. 644035.

[14] Shi, Y.Y., et al., The association between triglyceride glucose index and depression: data from NHANES 2005-2018. BMC Psychiatry, 2021. 21(1): p. 267.

[15] Yoon, J.H., et al., Association of Triglyceride-Glucose Index with Bone Mineral Density in Non-diabetic Koreans: KNHANES 2008-2011. Calcif Tissue Int, 2021. 108(2): p. 176-187.

[16] Wang, X., L. Jiang, and X. Shao, Association Analysis of Insulin Resistance and Osteoporosis Risk in Chinese Patients with T2DM. Ther Clin Risk Manag, 2021. 17: p. 909-916.

[17] Napoli, N., et al., Effect of Insulin Resistance on BMD and Fracture Risk in Older Adults. J Clin Endocrinol Metab, 2019. 104(8): p. 3303-3310.

[18] Paulose-Ram, R., et al., Overview of Asian American Data Collection, Release, and Analysis: National Health and Nutrition Examination Survey 2011-2018. Am J Public Health, 2017. 107(6): p. 916-921.

[19] Liu, B., et al., The association of diabetes status and bone mineral density among US adults: evidence from NHANES 2005-2018. BMC Endocr Disord, 2023. 23(1): p. 27.

[20] MacGregor, K.A., I.J. Gallagher, and C.N. Moran, Relationship Between Insulin Sensitivity and Menstrual Cycle Is Modified by BMI, Fitness, and Physical Activity in NHANES. J Clin Endocrinol Metab, 2021. 106(10): p. 2979-2990.

[21] McClure, S.T., et al., Dietary intake of adults with and without diabetes: results from NHANES 2013-2016. BMJ Open Diabetes Res Care, 2020. 8(1).

[22] Zhou, C., et al., Inverse Association Between Variety of Proteins With Appropriate Quantity From Different Food Sources and New-Onset Hypertension. Hypertension, 2022. 79(5): p. 1017-1027.

[23] Shi, Z., et al., The Circadian Syndrome Is a Significant and Stronger Predictor for Cardiovascular Disease than the Metabolic Syndrome-The NHANES Survey during 2005-2016. Nutrients, 2022. 14(24).

[24] Looker, A.C., et al., Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res, 1997. 12(11): p. 761-768.

[25] Li, T., et al., Elevated triglyceride-glucose index predicts mortality following endovascular abdominal aortic aneurysm repair. Front Nutr, 2023. 10: p. 1116425.

[26] Sakurai, T., et al., Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus. Gerontology, 2010. 56(2): p. 141-149.

[27] Yong, E.L. and S. Logan, Menopausal osteoporosis: screening, prevention and treatment. Singapore Med J, 2021. 62(4): p. 159-166.

[28] Zeng, Q., et al., The Prevalence of Osteoporosis in China, a Nationwide, Multicenter DXA Survey. J Bone Miner Res, 2019. 34(10): p. 1789-1797.

[29] Akash, M.S.H., K. Rehman, and A. Liaqat, Tumor Necrosis Factor-Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus. J Cell Biochem, 2018. 119(1): p. 105-110.

[30] Rehman, K., et al., Role of Interleukin-6 in Development of Insulin Resistance and Type 2 Diabetes Mellitus. Crit Rev Eukaryot Gene Expr, 2017. 27(3): p. 229-236.

[31] Wang, T. and C. He, TNF-α and IL-6: The Link between Immune and Bone System. Curr Drug Targets, 2020. 21(3): p. 213-227.

[32] Zhang, Q., et al., Association Between Bone Mineral Density and Lipid Profile in Chinese Women. Clin Interv Aging, 2020. 15: p. 1649-1664.

[33] Tang, X., et al., Associations of insulin resistance and beta-cell function with abnormal lipid profile in newly diagnosed diabetes. Chin Med J (Engl), 2022. 135(21): p. 2554-2562.

[34] Conte, C., S. Epstein, and N. Napoli, Insulin resistance and bone: a biological partnership. Acta Diabetol, 2018. 55(4): p. 305-314.

[35] Gopinath, V., Osteoporosis. Med Clin North Am, 2023. 107(2): p. 213-225.

[36] Jiang, X., et al., Osteoporosis screening in postmenopausal women aged 50-64 years: BMI alone compared with current screening tools. Maturitas, 2016. 83: p. 59-64.

[37] Alay, I., et al., The relation of body mass index, menopausal symptoms, and lipid profile with bone mineral density in postmenopausal women. Taiwan J Obstet Gynecol, 2020. 59(1): p. 61-66.

[38] Li, Q., et al., The effects of body mass index on insulin resistance in patients undergoing total hip arthroplasty: a pilot study. Int Orthop, 2022. 46(8): p. 1775-1782.

[39] Chen, M., et al., Non-linear associations of body mass index with impaired fasting glucose, β-cell dysfunction, and insulin resistance in nondiabetic Chinese individuals: a cross-sectional study. Endokrynol Pol, 2021. 72(6): p. 618-624.

[40] Ahmed, B., R. Sultana, and M.W. Greene, Adipose tissue and insulin resistance in obese. Biomed Pharmacother, 2021. 137: p. 111315.

[41] Rathinavelu, S., C. Guidry-Elizondo, and J. Banu, Molecular Modulation of Osteoblasts and Osteoclasts in Type 2 Diabetes. J Diabetes Res, 2018. 2018: p. 6354787.

[42] Napoli, N., et al., Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol, 2017. 13(4): p. 208-219.

[43] Wen, Y., et al., Correlation of Osteoporosis in Patients With Newly Diagnosed Type 2 Diabetes: A Retrospective Study in Chinese Population. Front Endocrinol (Lausanne), 2021. 12: p. 531904.

[44] Botolin, S., et al., Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. Endocrinology, 2005. 146(8): p. 3622-3631.

[45] Lebovitz, H.E., Insulin resistance--a common link between type 2 diabetes and cardiovascular disease. Diabetes Obes Metab, 2006. 8(3): p. 237-249.